Mayer-Hamblett, N ;
van Koningsbruggen-Rietschel, S ;
Nichols, D. P...
Mayer-Hamblett , N , van Koningsbruggen-Rietschel , S , Nichols , D P , VanDevanter , D R , Davies , J C , Lee , T , Durmowicz , A G , Ratjen , F , Konstan , M W , Pearson , K , Bell , S C , Clancy , J P , Taylor-Cousar , J L , De Boeck , K , Donaldson , S H , Downey , D G , Flume , P A , Drevinek , P , Goss , C H , Fajac , I , Magaret , A S , Quon , B S , Singleton , S M , VanDalfsen , J M & Retsch-Bogart , G Z 2020 , ' Building global development strategies for cf therapeutics during a transitional cftr modulator era ' , Journal of Cystic Fibrosis , vol. 19 , no. 5 , pp. 677-687 . https://doi.org/10.1016/j.jcf.2020.05.011.
,
2020
